New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 21, 2013
12:09 EDTACAD, CSCO, ORCL, GES, SVU, BX, SCHL, HPQ, DELLOn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday as Europe's woes continue, though purchasing managers' indexes for the U.S. and China were strong. Amidst the backdrop of ongoing negotiations in Cyprus and a wealth of economic data from around the globe, the major averages slumped at the open and have been range-bound ever since... ECONOMIC EVENTS: In the U.S., jobless claims rose 2K from the prior week to 336K, a bit below the forecast for an increase to 340K. The FHFA home price index for January rose 0.6% from the prior month, versus expectations for a 0.7% advance. The leading economic indicators rose 0.5% for February, versus expectations for an increase of 0.4%. Existing home sales rose 0.8% in February, versus expectations for a 1.6% monthly increase. The Philly Fed manufacturing survey reading for March came in at +2.0, versus expectations for a -3.0 reading. Markit's preliminary U.S. purchasing managers' index for March came in at 54.9, nearly matching the 54.8 consensus forecast. In China, HSBC's preliminary PMI reading for March was 51.7, which compares to a 50.4 final reading for February. In Europe, Markit's flash composite PMI for services and manufacturing fell to 46.5 in March from 47.9 in February. Also, the European Central Bank said it will cut Cypriot banks off from emergency funds after this Monday, March 25, unless a bailout agreement is struck with the EU and IMF... COMPANY NEWS: Oracle (ORCL) shares fell 8% and were downgraded at CLSA and Evercore following the company's disappointing earnings report. Oracle may also risk losing its president Mark Hurd, according to a report from Fortune. The publication said Blackstone (BX) is seriously considering a bid for Dell (DELL) and one of the PE firm's top choices to run Dell, assuming it chooses to bid, would be Oracle's Hurd... Cisco (CSCO) was by far the Dow's worst performer, sinking over 3% following Oracle's report and after FBR Capital downgraded Cisco to an Underperform rating in a note to investors earlier today... Hewlett-Packard (HPQ) raised its regular dividend by 10% after shareholders failed in an attempt to remove the company's two longest-serving directors at its annual meeting, held last night... MAJOR MOVERS: Among the notable gainers was SuperValu (SVU), which rose more than 6% after it completed the sale of several of its chains to a private equity firm consortium in a deal valued at $3.3B, including $100M in cash and $3.2B in debt assumption. Also higher were shares of ACADIA Pharmaceuticals (ACAD), up 29% after presenting detailed results from a Phase III study of its treatment for Parkinson's disease psychosis. Among the noteworthy losers following their earnings reports were Scholastic (SCHL), which fell 14%, and Guess (GES), which declined nearly 5%... INDICES: Near noon, the Dow was down 35.83, or 0.25%, to 14,475.90; the Nasdaq was down 20.01, or 0.61%, to 3,234.18; and the S&P 500 was down 4.80, or 0.31%, to 1,553.91.
News For ORCL;DELL;BX;CSCO;HPQ;SVU;ACAD;SCHL;GES From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 >>
August 25, 2015
09:35 EDTCSCOActive equity options trading on open
Subscribe for More Information
09:07 EDTACADACADIA initiated with a Buy at Aegis
Subscribe for More Information
07:24 EDTORCLRentrak weakness a buying opportunity, says Brean Capital
Subscribe for More Information
August 21, 2015
17:28 EDTBXBlackstone acquires majority stake in Stearns Holdings
Subscribe for More Information
16:38 EDTACADACADIA unit manufacturing agreement with BASF Pharma
On August 17, our Swiss subsidiary, ACADIA Pharmaceuticals GmbH, entered into a co-operation agreement and product schedule, collectively referred to as the manufacturing agreement, with BASF Pharma SA, or BASF. Under the manufacturing agreement, BASF has agreed to manufacture and supply pimavanserin tartrate, the active pharmaceutical ingredient of NUPLAZID, for commercial use. The term of the manufacturing agreement extends through December 31, 2020 and will automatically renew for subsequent one year terms unless either party provides timely notice of its intent not to renew, or unless the manufacturing agreement is terminated earlier pursuant to its terms.
16:01 EDTHPQOptions Update; August 21, 2015
Subscribe for More Information
12:43 EDTHPQJim Chanos says still long Apple, short HP
Subscribe for More Information
12:43 EDTHPQJim Chanos says still short shares of HP
Jim Chanos of Kynikos Associates is speaking on CNBC
12:13 EDTCSCOBrocade soars after Q3 results top estimates
Subscribe for More Information
12:04 EDTHPQOn The Fly: Top stock stories at midday
Subscribe for More Information
10:37 EDTHPQAnalysts upbeat on HP ahead of split after earnings beat
Subscribe for More Information
09:22 EDTHPQHP CEO says both companies will have over 50% shareholder return
Subscribe for More Information
07:47 EDTHPQHP should be bought at current levels, says Bernstein
Subscribe for More Information
07:43 EDTHPQHP risk/reward remains favorable, says UBS
Subscribe for More Information
07:32 EDTHPQHP guidance will likely leave stock flattish, says Brean Capital
Brean Capital noted HP beat Q2 earnings estimates but believes its guidance will likely leave the stock flattish. The firm expects ongoing PC consolidation, continued cost savings, and for HP to gain incremental traction in its go-forward Enterprises solutions and Services strategy. Brean Capital reiterated its Buy rating and $45 price target on HP shares.
07:26 EDTHPQHP results 'a net positive,' says Stifel
Subscribe for More Information
07:16 EDTHPQHP didn't deliver bad news for first time in several quarters, says Citi
Subscribe for More Information
06:49 EDTHPQHP enterprise portfolio being underappreciated, says Deutsche Bank
Deutsche Bank analyst Sherri Scribner says HP's Q3 results beat expectations while a shift in some earnings into the quarter from Q4 drove "modestly disappointing" guidance. While PCs are weak, HP's Enterprise Group "significantly outperformed expectations," Scribner tells investors in a post-earnings research note. The analyst believes the company's enterprise portfolio is being underappreciated by investors and that the upcoming split should be a positive for shares. She views HP's valuation as compelling and keeps a Buy rating on the stock with a $45 price target.
06:01 EDTHPQABI Research: Portable PC sales to remain flat in 2015, DigiTimes says
Subscribe for More Information
05:51 EDTHPQHP implied volatility of 40 at upper end of index
Subscribe for More Information
1 | 2 | 3 | 4 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use